Literature DB >> 17624337

Decreased anti-Müllerian hormone and altered ovarian follicular cohort in infertile patients with mild/minimal endometriosis.

Nadiane Albuquerque Lemos1, Elisangela Arbo, Renata Scalco, Eduardo Weiler, Virginia Rosa, João Sabino Cunha-Filho.   

Abstract

OBJECTIVE: To evaluate the ovarian reserve and follicular cohort of infertile patients with minimal/mild endometriosis.
DESIGN: Prospective study.
SETTING: University hospital. PATIENT(S): Patients were divided into two groups: group I, minimal/mild endometriosis and group II, tubal obstruction. The following exclusion criteria were established: [1] patients with previous endocrine disorders; and [2] cases in which the cause for infertility was other than endometriosis (except for patients with tubal obstruction, in the control group). INTERVENTION(S): Serum FSH and anti-Müllerian hormone were measured on day 3. On the same day all patients were submitted to transvaginal ultrasound to evaluate the antral follicular count and the ovarian follicular cohort. MAIN OUTCOME MEASURE(S): Serum FSH, anti-Müllerian hormone, and the follicular cohort with the respective antral follicular count. RESULT(S): Serum FSH were not different between the groups. However, infertile patients with endometriosis have a decreased serum anti-Müllerian hormone (1.26 +/- 0.7 ng/mL) compared to the control group (2.02 +/- 0.72 ng/mL). The analysis of follicular cohort showed that the number of selectable follicles were similar, but the follicular diameter was different. CONCLUSION(S): Minimal/mild endometriosis is associated with a decrease in the follicular ovarian reserve. In addition, the follicular cohort of these patients is more heterogeneous in comparison to the control group.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17624337     DOI: 10.1016/j.fertnstert.2007.04.048

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  23 in total

1.  LH (Trp8Arg/Ile15Thr), LHR (insLQ) and FSHR (Asn680Ser) polymorphisms genotypic prevalence in women with endometriosis and infertility.

Authors:  Carla Regina Schmitz; Carlos Augusto Bastos de Souza; Vanessa Krebs Genro; Ursula Matte; Emily de Conto; João Sabino Cunha-Filho
Journal:  J Assist Reprod Genet       Date:  2015-05-03       Impact factor: 3.412

2.  Medical Management of Endometriosis.

Authors:  Saima Rafique; Alan H Decherney
Journal:  Clin Obstet Gynecol       Date:  2017-09       Impact factor: 2.190

3.  Impact of endometriosis on in vitro fertilization outcomes: an evaluation of the Society for Assisted Reproductive Technologies Database.

Authors:  Suneeta Senapati; Mary D Sammel; Christopher Morse; Kurt T Barnhart
Journal:  Fertil Steril       Date:  2016-04-07       Impact factor: 7.329

4.  The effect of endometriosis on the antimüllerian hormone level in the infertile population.

Authors:  Phillip A Romanski; Paula C Brady; Leslie V Farland; Ann M Thomas; Mark D Hornstein
Journal:  J Assist Reprod Genet       Date:  2019-04-16       Impact factor: 3.412

Review 5.  Managing endometriosis-associated infertility.

Authors:  Suneeta Senapati; Kurt Barnhart
Journal:  Clin Obstet Gynecol       Date:  2011-12       Impact factor: 2.190

6.  Age-specific reference values and cut-off points for anti-müllerian hormone in infertile women following a long agonist treatment protocol for IVF.

Authors:  Z Heidar; M Bakhtiyari; F Foroozanfard; M Mirzamoradi
Journal:  J Endocrinol Invest       Date:  2017-12-12       Impact factor: 4.256

7.  Endometriosis-associated infertility: GDF-9, AMH, and AMHR2 genes polymorphisms.

Authors:  Emily De Conto; Úrsula Matte; João Paolo Bilibio; Vanessa Krebs Genro; Carlos Augusto Souza; Delva Pereira Leão; João Sabino Cunha-Filho
Journal:  J Assist Reprod Genet       Date:  2017-08-22       Impact factor: 3.412

8.  The role of fertility preservation in patients with endometriosis.

Authors:  L Carrillo; D S Seidman; E Cittadini; D Meirow
Journal:  J Assist Reprod Genet       Date:  2016-01-14       Impact factor: 3.412

9.  CONTROLLED OVARIAN STIMULATION IN ENDOMETRIOSIS PATIENTS CAN BE INDIVIDUALIZED BY ANTI-MÜLLERIAN HORMONE LEVELS.

Authors:  E Hosseini; F Nikmard; B Aflatoonian; S Vesali; T Alenabi; A Aflatoonian; F Mehraein; R Aflatoonian
Journal:  Acta Endocrinol (Buchar)       Date:  2017 Apr-Jun       Impact factor: 0.877

10.  Serum anti-Müllerian hormone is a better predictor of ovarian response than FSH and age in IVF patients with endometriosis.

Authors:  Ji Hee Yoo; Sun Hwa Cha; Chan Woo Park; Jin Young Kim; Kwang Moon Yang; In Ok Song; Mi Kyoung Koong; Inn Soo Kang; Hye Ok Kim
Journal:  Clin Exp Reprod Med       Date:  2011-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.